BioCatalystWatch
ANIXWorkspace / ANIX / OverviewCompany library
ANIXA BIOSCIENCES, INC. logo

ANIXA BIOSCIENCES, INC.

ANIXA BIOSCIENCES, INC. (ANIX)

Website

Price
Market cap
Next catalystExpected 2026Breast Cancer Vaccine · Regulatory meetingCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Lira-cel (liraltagene autoleucel)

FSHR

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Lira-cel (liraltagene autoleucel)

FSHR

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Lira-cel (liraltagene autoleucel)

FSHR

CAR-T technology

FSHR

PreINDP1P2P3FilingApproved
Ovarian Cancer Vaccine

Vaccine

AMHR2-ED

PreINDP1P2P3FilingApproved

Approved / commercial

History / paused

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ANIX PR & News

PR & News

ANIX SEC archive